Copyright
©The Author(s) 2015.
World J Gastroenterol. Apr 21, 2015; 21(15): 4680-4687
Published online Apr 21, 2015. doi: 10.3748/wjg.v21.i15.4680
Published online Apr 21, 2015. doi: 10.3748/wjg.v21.i15.4680
Table 4 Human epidermal growth factor receptor 2 amplification status and survival analyses
| Treatment | HER2 amplification | No. of cases | Survival analysis (mo) | |
| Median PFS | Median OS | |||
| Chemotherapy alone | Cluster | 7 | 6.3 | 11.9 |
| Large granule | 6 | 5.8 | 12.2 | |
| Dot | 4 | 5.3 | 11.6 | |
| HH-17 | 2 | 5.1 | 12.7 | |
| Trastuzumab combined with chemotherapy | Cluster | 9 | 10.7 | 18.1 |
| Large granule | 6 | 9.9 | 17.7 | |
| Dot | 5 | 8.3 | 16.5 | |
| HH-17 | 2 | 7.6 | 14.3 | |
- Citation: Wang YK, Chen Z, Yun T, Li CY, Jiang B, Lv XX, Chu GH, Wang SN, Yan H, Shi LF. Human epidermal growth factor receptor 2 expression in mixed gastric carcinoma. World J Gastroenterol 2015; 21(15): 4680-4687
- URL: https://www.wjgnet.com/1007-9327/full/v21/i15/4680.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i15.4680